Silkworm (Bombyx mori L.) reduces vasopressin expression in the hypothalamus of streptozotocin-induced diabetic mice

Neurological Research

Volumn 29, Issue SUPPL. 1, 2007, Pages

  Kim, Mi Ja ^a   Hong, Seung Jae ^b   Yang, JongSoo ^c   Kim, Hye Kyung ^d  

^a Dongduk Women's University   (South Korea)

^b Bundang CHA Hospital   (South Korea)

^c ITEP   (South Korea)

^d Hanseo University   (South Korea)

Author keywords

Diabetic neuropathy; Hypothalamus; Silkworm; Vasopressin

Indexed keywords

GLUCOSE; STREPTOZOCIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIET THERAPY; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; MEASUREMENT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SILKWORM; STREPTOZOCIN DIABETES; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; BLOOD GLUCOSE; BOMBYX; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; HYPOTHALAMUS; KOREA; MALE; MEDICINE, ORIENTAL TRADITIONAL; MICE; MICE, INBRED ICR; NEURONS; TISSUE EXTRACTS; VASOPRESSINS;

EID: 33947575798     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X172374     Document Type: Article

References (21)

1. Ekstrom PA, Tomlinson DR. Impaired nerve regeneration in streptozotocin-diabetic rats in improved by treatment with gangliosides. Exp Neurol 1990; 109: 200-203
2. Feldmen EL, Stevens MJ, Greene DA. Pathogenesis of diabetic neuropathy. Clin Neurosci 1997; 4: 365-370
3. Gainer H. Cell-specific gene expression in oxytocin and vasopressin magnocellular neurons. Adv Exp Med Biol 1998; 449: 15-27
4. Brooks DP, Nutting DF, Crofton JT, et al. Vasporessin in rats with genetic and streptozocin-induced diabtes. Diabetes 1989; 38: 54-57
5. Serino R, Ueta Y, Tokunaga M, et al. Upregulation of hypothalamic nitric oxide synthase gene expression in streptozotocin-induced diabetic rats. Diabetogia 1998; 41: 640-648
6. Zerbe RL, Vinicor F, Robertson GL. Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 1979; 28: 503-508
7. Dheen ST, Tay SS, Wong WC. Arginine vasopressin- and oxytocin-like immunoreactive neurons in the hypothalamic paraventricular and supraoptic nuclei of streptozotocin-induced diabetic rats. Arch Histol Cytol 1994; 57: 461-472
8. Dheen ST, Tay SS, Wong WC. Ultrastructural changes in the hypothalamic paraventricular nucleus of the streptozotocin-induced diabetic rat. Acta Anat (Basel) 1994; 149: 291-299
9. Dheen ST, Tay SS, Wong WC. Ultrastructural changes in the hypothalamic supraoptic nucleus of the streptozotocin-induced diabetic rat. J Anat 1994; 184: 615-623
10. Kadowaki K, Kishimoto J, Leng G, et al. Up-regulation of nitric oxide synthase (NOS) gene expression together with NOS activity in the at hypothalamo-hypophysial system after chronic salt loading: Evidence of a neuromodulatory role of nitric oxide in arginine vasopressin and oxytocin secretion. Endocrinology 1994; 134: 1011-1117
11. Kang YK, Choo SK, Nam SH. The effect of silkworm-extract on blood components levels in mice. Korean J Entomol 2001; 31: 243-247
12. Saravia FE, Gonzalez S, Roig P, et al. Diabetes increases the expression of hypothalamic neuropeptides in a spontaneous model of type I diabetes, the nonobese diabetic (NOD) mouse. Cell Mol Neurobiol 2001; 21: 15-27
13. Van Itallie CM, Fernstrom JD. Osmotal effects on vasopressin secretion in the streptozotocin-diabetes rat. Am J Physiol 1982; 242: E4T1-E417
14. Klein JP, Hains BC, Craner MJ, et al. Apoptosis of vasopressinergic hypothalamic neurons in chronic diabetes mellitus. Neurobiol Dis 2004; 15: 221-228
15. Li PA, Siesjo BK. Role of hyperglycemia-related acidosis in ischemic: brain damage. Acta Physiol Scand 1997; 161: 567-580
16. Gisselsson L, Smith ML, Siesjo BK. Hyperglycemia and focal brain ischemia. J Cereb Blood Flow Metab 1999; 19: 288-297
17. Fernstrom J, Fernstrom M, Kwok R. In vivo somatostatin, vasopressin and oxytocin synthesis in diabetic rat hypothalamus. Am J Physiol 1990; 258: E661-E666
18. Asano N, Yamashita T, Yasuda K, et al. Polyhydroxylated alkaloids isolated from mulberry trees (Morusalba L.) and silkworms (Bombyx mori L.). J Agric Food Chem 2001; 49: 4208-4213
19. Ryu KS, Lee HS, Chung SH, et al. An activity of lowering blood-glucose levels according to preparative conditions of silkworm powder. Korean J Seric Sci 1997; 39: 79-85
20. Hikino H, Mizuno T, Oshima T, et al. Isolation and hypoglycemic activity of moran A, a glycoprotein of Morus alba root barks. Planta Med 1985; 51: 159-160
21. Kimura M, Chen FJ, Nakashima N, et al. Antihyperglycemic effects of N-containing sugars derived from mulberry leaves in streptozocin-induced diabetic mice. J Trad Med 1995; 12: 214-219